TY - JOUR
T1 - Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase
AU - Szabó, Csaba
AU - Virág, László
AU - Cuzzocrea, Salvatore
AU - Scott, Gwen S.
AU - Hake, Paul
AU - O'Connor, Michael P.
AU - Zingarelli, Basilia
AU - Salzman, Andrew
AU - Kun, Ernest
PY - 1998/3/31
Y1 - 1998/3/31
N2 - Peroxynitrite, a cytotoxic oxidant formed from nitric oxide (NO) and superoxide, induces DNA strand breakage, which activates the nuclear enzyme poly(ADP-ribose) synthase (PARS; EC 2.4.2.30). The cellular function of PARS was determined in fibroblast lines from PARS knockout animals (PARS(-/-)) and corresponding wild-type animals (PARS(+/+)), with the aid of lipophilic PARS inhibitor 5-iodo-6-amino-1,2-benzopyrone (INH2BP). We investigated the role of PARS in peroxynitrite-induced fibroblast injury in vitro and also in the development of arthritis in vivo. Exposure of embryonic fibroblasts from the PARS(+/+) animals to peroxynitrite caused DNA single-stand breakage and PARS activation and caused an acute suppression of mitochondrial respiration. INH2BP protected the PARS(+/+) cells against the suppression of mitochondrial respiration in response to peroxynitrite (50-100 μM). Similarly to PARS inhibition with INH2BP, the PARS(-/-) cells were protected against peroxynitrite-induced injury. The protection against cellular injury by PARS(-/-) phenotype or INH2BP waned when cells were challenged with higher concentrations of the oxidant. Inhibition of PARS by INH2BP or by PARS(-/-) phenotype reduced inducible nitric-oxide synthase (iNOS; EC 1.14.13.39) mRNA levels and inhibited production of NO in immunostimulated cells. INH2BP had no peroxynitrite scavenging or hydroxyl radical scavenging effects, and it exerted no additional (nonspecific) effects in the PARS(-/-) cells. In collagen-induced arthritis, significant staining for nitrotyrosine, a marker of peroxynitrite formation, was found in the inflamed joints. Oral treatment with INH2BP (0.5 g/kg, daily), starting at the onset of arthritis (day 25), delayed the development of the clinical signs at days 26-35 and improved histological status in the knee and paw. Our data demonstrate that deletion of PARS by genetic manipulation or pharmacological inhibition of PARS protects against oxidant-induced cellular injury in vitro and exhibits anti-inflammatory effects in vivo.
AB - Peroxynitrite, a cytotoxic oxidant formed from nitric oxide (NO) and superoxide, induces DNA strand breakage, which activates the nuclear enzyme poly(ADP-ribose) synthase (PARS; EC 2.4.2.30). The cellular function of PARS was determined in fibroblast lines from PARS knockout animals (PARS(-/-)) and corresponding wild-type animals (PARS(+/+)), with the aid of lipophilic PARS inhibitor 5-iodo-6-amino-1,2-benzopyrone (INH2BP). We investigated the role of PARS in peroxynitrite-induced fibroblast injury in vitro and also in the development of arthritis in vivo. Exposure of embryonic fibroblasts from the PARS(+/+) animals to peroxynitrite caused DNA single-stand breakage and PARS activation and caused an acute suppression of mitochondrial respiration. INH2BP protected the PARS(+/+) cells against the suppression of mitochondrial respiration in response to peroxynitrite (50-100 μM). Similarly to PARS inhibition with INH2BP, the PARS(-/-) cells were protected against peroxynitrite-induced injury. The protection against cellular injury by PARS(-/-) phenotype or INH2BP waned when cells were challenged with higher concentrations of the oxidant. Inhibition of PARS by INH2BP or by PARS(-/-) phenotype reduced inducible nitric-oxide synthase (iNOS; EC 1.14.13.39) mRNA levels and inhibited production of NO in immunostimulated cells. INH2BP had no peroxynitrite scavenging or hydroxyl radical scavenging effects, and it exerted no additional (nonspecific) effects in the PARS(-/-) cells. In collagen-induced arthritis, significant staining for nitrotyrosine, a marker of peroxynitrite formation, was found in the inflamed joints. Oral treatment with INH2BP (0.5 g/kg, daily), starting at the onset of arthritis (day 25), delayed the development of the clinical signs at days 26-35 and improved histological status in the knee and paw. Our data demonstrate that deletion of PARS by genetic manipulation or pharmacological inhibition of PARS protects against oxidant-induced cellular injury in vitro and exhibits anti-inflammatory effects in vivo.
KW - DNA single-strand break
KW - Inducible nitric-oxide synthase
KW - Inflammation
KW - Nitric oxide
KW - Superoxide
UR - http://www.scopus.com/inward/record.url?scp=0032584164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032584164&partnerID=8YFLogxK
U2 - 10.1073/pnas.95.7.3867
DO - 10.1073/pnas.95.7.3867
M3 - Article
C2 - 9520459
AN - SCOPUS:0032584164
SN - 0027-8424
VL - 95
SP - 3867
EP - 3872
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 7
ER -